Synaptic phospholipids as a new target for cortical hyperexcitability and E/I balance in psychiatric disorders

  • Lysophosphatidic acid (LPA) is a synaptic phospholipid, which regulates cortical excitation/inhibition (E/I) balance and controls sensory information processing in mice and man. Altered synaptic LPA signaling was shown to be associated with psychiatric disorders. Here, we show that the LPA-synthesizing enzyme autotaxin (ATX) is expressed in the astrocytic compartment of excitatory synapses and modulates glutamatergic transmission. In astrocytes, ATX is sorted toward fine astrocytic processes and transported to excitatory but not inhibitory synapses. This ATX sorting, as well as the enzymatic activity of astrocyte-derived ATX are dynamically regulated by neuronal activity via astrocytic glutamate receptors. Pharmacological and genetic ATX inhibition both rescued schizophrenia-related hyperexcitability syndromes caused by altered bioactive lipid signaling in two genetic mouse models for psychiatric disorders. Interestingly, ATX inhibition did not affect naive animals. However, as our data suggested that pharmacological ATX inhibition is a general method to reverse cortical excitability, we applied ATX inhibition in a ketamine model of schizophrenia and rescued thereby the electrophysiological and behavioral schizophrenia-like phenotype. Our data show that astrocytic ATX is a novel modulator of glutamatergic transmission and that targeting ATX might be a versatile strategy for a novel drug therapy to treat cortical hyperexcitability in psychiatric disorders.

Download full text files

Export metadata

Metadaten
Author:Carine Thalman, Guilherme Horta, Lianyong Qiao, Heiko EndleORCiD, Irmgard TegederORCiD, Hong Cheng, Gregor Laube, Torfi SigurdssonORCiD, Maria Jelena Hauser, Stefan TenzerORCiDGND, Ute DistlerORCiDGND, Junken Aoki, Andrew J. Morris, Gerd GeisslingerORCiDGND, Jochen Röper, Sergei Kirischuk, Heiko Luhmann, Konstantin Radyushkin, Robert NitschGND, Johannes VogtORCiD
URN:urn:nbn:de:hebis:30:3-508511
DOI:https://doi.org/10.1038/s41380-018-0053-1
ISSN:1476-5578
ISSN:1359-4184
Pubmed Id:https://pubmed.ncbi.nlm.nih.gov/29743582
Parent Title (English):Molecular psychiatry
Publisher:Macmillan
Place of publication:London
Document Type:Article
Language:English
Year of Completion:2018
Date of first Publication:2018/05/09
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2019/08/29
Tag:Neuroscience; Schizophrenia
Volume:23
Issue:8
Page Number:12
First Page:1699
Last Page:1710
Note:
Open Access: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Note:
Correction erschienen in: Molecular psychiatry, 24.2019, doi:10.1038/s41380-018-0320-1
HeBIS-PPN:453937268
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung 4.0